Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
BW Businessworld

Ta Associates Acquires Synokem Pharma For $125 Mn

Founded in 1983 by J.M. Arora, Synokem Pharmaceuticals serves customers in the branded generic domestic formulations market

Photo Credit :

1491334560_c8wExI_1484239743_E3evv6_deals.jpg

TA Associates, a leading global growth private equity firm, acquired a majority stake in Synokem Pharmaceuticals - a contract development and manufacturing organization, in a deal worth Rs 1000 crore (USD 125 million).

Synokem’s founders will continue as shareholders in the company alongside TA, stated the press release.

Founded in 1983 by J.M. Arora, Synokem Pharmaceuticals serves customers in the branded generic domestic formulations market. In addition, the New Delhi-based company’s products are exported to more than 30 countries.

“The company has delivered numerous fiRs t-to-market products which is further indicative of its industry-leading position. We believe Synokem can serve as a high-quality producer of pharma products, not just for India but also for international markets. We are excited to partner with Synokem’s management team to drive growth, including through strategic acquisitions,” said Dhiraj Poddar, Managing Director and Head of Indian operations for TA Associates Advisory.

“With industry expansion being driven by both demographic and economic factors, including higher health insurance penetration and affordability, we believe there is a strong opportunity to build on Synokem’s momentum and further expand its capabilities,” added Vishal Gupta, Director at TA.

“We believe TA is an ideal partner for Synokem as we enter the next phase of our journey,” said Abhinav Arora, Managing Director of Synokem.

“The firm’s deep industry knowledge and experience scaling companies like ours  will meaningfully boost our ability to pursue both organic and inorganic growth, thereby increasing our market share and further positioning Synokem as an industry leader,” he added.

TA Associates has invested in more than 560 companies around the world. TA has raised USD 48.6 billion in capital since its founding in 1968.


Tags assigned to this article:
pharmaceutical acquisition TA Associates healthcare deal